Specialty chemicals products and functional solutions for pharmaceuticals, personal & home care and crop care
Ashland Inc.
Cabreúva, Brazil · Mullingar, Ireland · Zwijndrecht, Netherlands · Bridgewater, New Jersey, USANew on Amplifa
About Ashland
Ashland is a US specialty chemicals group (formerly Ashland Oil, named after Ashland, Kentucky) that develops and produces additives and functional materials for the pharmaceutical, personal and home care, and crop care industries. The portfolio includes, among others, cellulose derivatives such as Klucel LS (low-substituted hydroxypropylcellulose) for oral solid doses, bioresorbable polymers of the Viatel brand for injectables, modified starches, emulsifiers such as Effisin EM, wetting agents such as EasyHance, and Agrimer Eco Disperse OD for agricultural applications. The value chain ranges from research and development through central R&D laboratories to pharmaceutical production. Locations include the expanded pharmaceutical manufacturing plant in Cabreúva (Brazil), the injectables production and R&D site in Mullingar (Ireland), the Central R&D EMEA laboratory in Zwijndrecht (Netherlands), and the technology center in Bridgewater, New Jersey (USA). In addition to internal R&D, Ashland pursues an open innovation model with partners from industry, academia and start-ups.
- Site
- Cabreúva
- Processes
- Pharmaceutical manufacturing (oral solid/injectables), Research & Development (Central R&D), Open innovation partnerships (Open Innovation)
- Materials
- Klucel LS (low substituted hydroxypropylcellulose), Viatel Bioresorbable Polymers, Agrimer Eco Disperse OD, Effisin EM (natural multifunctional), EasyHance wetting agent, Modified starch (multifunctional starch platform), Klucel LS (low-substituted hydroxypropylcellulose), Viatel bioresorbable polymers
- Industries
- Pharmaceuticals (oral solid doses, injectables), Personal & Home Care (hair, skin and sun care), Crop Care (agricultural adjuvants and inerts)
- 01
Research & Development (Central R&D)
- 02
Open innovation with partners
- 03
Production of pharmaceutical excipients and functional polymers
- 04
Application technology support for customers
Products and Material Platforms
Klucel LS (low-substituted hydroxypropylcellulose)
Cellulose derivative for oral solid doses in pharmaceuticals.
Viatel bioresorbable polymers
Bioresorbable polymers for pharmaceutical injectables, produced and researched in Mullingar, Ireland.
Agrimer Eco Disperse OD
Dispersant for agricultural adjuvants and inerts in the crop care sector.
Effisin EM (natural multifunctional)
Natural multifunctional product for skin and sun care.
EasyHance wetting agent
Wetting agent for hair care applications in the personal care sector.
Modified starch (multifunctional starch platform)
Multifunctional starch platform with scalable applications, presented at the Innovation Day.
Locations
Cabreúva
BRPharmaceutical manufacturing plant (expanded)
- Pharmaceutical production facilities
Mullingar
IEProduction and R&D laboratory for bioresorbable polymers (second expansion)
- Materials
- Viatel bioresorbable polymers
- Injectables production
- R&D laboratory
Bridgewater, New Jersey
USTechnology center / Innovation Day venue
Zwijndrecht
NLCentral R&D EMEA laboratory
- R&D laboratories
Product Platforms
Inside the production
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Pharmaceutical manufacturing (oral solid/injectables)Assembly | – | – | – | – | Cellulose derivatives (Klucel), bioresorbable polymers |
4 Anlagen & Maschinen
| Machine | Manufacturer / model | Quantity | Working area | Year built | Site |
|---|---|---|---|---|---|
| Pharmaceutical manufacturing plant | Ashland | – | – | – | Cabreúva, Brazil |
| Manufacturing and R&D lab (pharmaceutical injectables) | Ashland | – | – | – | Mullingar, Ireland |
| Central R&D EMEA Lab | Ashland | – | – | – | Zwijndrecht, Netherlands |
| Technology center / facility | Ashland | – | – | – | Bridgewater, New Jersey, USA |
Additional services
History
- 2025
Innovation Day for analysts and investors in Bridgewater, New Jersey
Expansion of the pharmaceutical manufacturing plant in Cabreúva, Brazil, completed
Second expansion of the injectables production and R&D site in Mullingar, Ireland
Opening of the new Central R&D EMEA laboratory in Zwijndrecht, Netherlands